Erratum to: Performance of Hemodialysis with Novel Medium Cut-Off Dialyzers

Performance of Hemodialysis with Novel Medium Cut-Off Dialyzers, Nephrol Dial Transplant; 2016; gfw310. doi.org/10.1093/ndt/gfw310

In the original article, there were inaccuracies within the reporting of data in Table 4 and Table 5. The data was reported as mean +/− SD instead of Least Square mean +/− SE.

The correct version of Table 4 is as follows:

Table 4

Open in new tab

(A) Overall clearances and (B) reduction ratios of medium-sized and small solutes in hemodialysis treatments in study 1

Cases	MCO AA HD	MCO BB HD	MCO CC HD	High-flux HD
(A) Overall clearance (mL/min)
α1-microglobulin	3.8 (0.39)*	5.2 (0.37)*	7.0 (0.38)*	0.1 (0.37)
Complement factor D	26.5 (1.11)*	30.4 (1.04)*	34.6 (1.07)*	1.8 (1.04)
Myoglobin	52.0 (2.48)*	59.3 (2.33)*	68.1 (2.47)*	11.9 (2.33)
β2-microglobulin	67.9 (2.29)*	71.9 (2.15)*	75.7 (2.28)*	26.1 (2.15)
Creatinine	159.5 (3.60)	159.9 (3.50)	162.6 (3.54)	157.2 (3.50)
Phosphate	172.8 (4.84)*	179.8 (4.74)*	187.4 (4.78)*	152.8 (4.74)
Urea	216.9 (4.77)**	216.7 (4.65)**	217.2 (4.70)**	208.2 (4.65)
(B) Reduction ratio (%)
YKL-40	60.5 (1.66)*	66.4 (1.66)*	70.8 (1.66)*	19.2 (1.69)
α1-microglobulin	21.7 (2.42)*	22.6 (2.42)	29.3 (2.42)*	7.7 (2.48)
Complement factor D	56.9 (1.30)*	61.7 (1.30)*	64.4 (1.30)*	16.6 (1.33)
Myoglobin	63.1 (2.09)*	67.2 (2.09)*	68.9 (2.14)*	8.6 (2.14)
β2-microglobulin	71.5 (1.35)*	72.0 (1.35)*	72.1 (1.36)*	53.0 (1.36)
Creatinine	64.3 (1.31)**	62.9 (1.31)	63.1 (1.31)	62.5 (1.31)
Phosphate	58.8 (2.37)	56.9 (2.37)	57.6 (2.37)	56.8 (2.37)
Urea	71.3 (1.22)**	70.5 (1.22)	71.1 (1.22)	70.1 (1.22)

Cases	MCO AA HD	MCO BB HD	MCO CC HD	High-flux HD
(A) Overall clearance (mL/min)
α1-microglobulin	3.8 (0.39)*	5.2 (0.37)*	7.0 (0.38)*	0.1 (0.37)
Complement factor D	26.5 (1.11)*	30.4 (1.04)*	34.6 (1.07)*	1.8 (1.04)
Myoglobin	52.0 (2.48)*	59.3 (2.33)*	68.1 (2.47)*	11.9 (2.33)
β2-microglobulin	67.9 (2.29)*	71.9 (2.15)*	75.7 (2.28)*	26.1 (2.15)
Creatinine	159.5 (3.60)	159.9 (3.50)	162.6 (3.54)	157.2 (3.50)
Phosphate	172.8 (4.84)*	179.8 (4.74)*	187.4 (4.78)*	152.8 (4.74)
Urea	216.9 (4.77)**	216.7 (4.65)**	217.2 (4.70)**	208.2 (4.65)
(B) Reduction ratio (%)
YKL-40	60.5 (1.66)*	66.4 (1.66)*	70.8 (1.66)*	19.2 (1.69)
α1-microglobulin	21.7 (2.42)*	22.6 (2.42)	29.3 (2.42)*	7.7 (2.48)
Complement factor D	56.9 (1.30)*	61.7 (1.30)*	64.4 (1.30)*	16.6 (1.33)
Myoglobin	63.1 (2.09)*	67.2 (2.09)*	68.9 (2.14)*	8.6 (2.14)
β2-microglobulin	71.5 (1.35)*	72.0 (1.35)*	72.1 (1.36)*	53.0 (1.36)
Creatinine	64.3 (1.31)**	62.9 (1.31)	63.1 (1.31)	62.5 (1.31)
Phosphate	58.8 (2.37)	56.9 (2.37)	57.6 (2.37)	56.8 (2.37)
Urea	71.3 (1.22)**	70.5 (1.22)	71.1 (1.22)	70.1 (1.22)

LS mean +/- standard error

Comparisons are based on a mixed model with fixed effects of period and study dialyzer type, and the random effect of subject.

*P < 0.001; **P < 0.05; (all versus HD).

Table 4

Open in new tab

(A) Overall clearances and (B) reduction ratios of medium-sized and small solutes in hemodialysis treatments in study 1

Cases	MCO AA HD	MCO BB HD	MCO CC HD	High-flux HD
(A) Overall clearance (mL/min)
α1-microglobulin	3.8 (0.39)*	5.2 (0.37)*	7.0 (0.38)*	0.1 (0.37)
Complement factor D	26.5 (1.11)*	30.4 (1.04)*	34.6 (1.07)*	1.8 (1.04)
Myoglobin	52.0 (2.48)*	59.3 (2.33)*	68.1 (2.47)*	11.9 (2.33)
β2-microglobulin	67.9 (2.29)*	71.9 (2.15)*	75.7 (2.28)*	26.1 (2.15)
Creatinine	159.5 (3.60)	159.9 (3.50)	162.6 (3.54)	157.2 (3.50)
Phosphate	172.8 (4.84)*	179.8 (4.74)*	187.4 (4.78)*	152.8 (4.74)
Urea	216.9 (4.77)**	216.7 (4.65)**	217.2 (4.70)**	208.2 (4.65)
(B) Reduction ratio (%)
YKL-40	60.5 (1.66)*	66.4 (1.66)*	70.8 (1.66)*	19.2 (1.69)
α1-microglobulin	21.7 (2.42)*	22.6 (2.42)	29.3 (2.42)*	7.7 (2.48)
Complement factor D	56.9 (1.30)*	61.7 (1.30)*	64.4 (1.30)*	16.6 (1.33)
Myoglobin	63.1 (2.09)*	67.2 (2.09)*	68.9 (2.14)*	8.6 (2.14)
β2-microglobulin	71.5 (1.35)*	72.0 (1.35)*	72.1 (1.36)*	53.0 (1.36)
Creatinine	64.3 (1.31)**	62.9 (1.31)	63.1 (1.31)	62.5 (1.31)
Phosphate	58.8 (2.37)	56.9 (2.37)	57.6 (2.37)	56.8 (2.37)
Urea	71.3 (1.22)**	70.5 (1.22)	71.1 (1.22)	70.1 (1.22)

Cases	MCO AA HD	MCO BB HD	MCO CC HD	High-flux HD
(A) Overall clearance (mL/min)
α1-microglobulin	3.8 (0.39)*	5.2 (0.37)*	7.0 (0.38)*	0.1 (0.37)
Complement factor D	26.5 (1.11)*	30.4 (1.04)*	34.6 (1.07)*	1.8 (1.04)
Myoglobin	52.0 (2.48)*	59.3 (2.33)*	68.1 (2.47)*	11.9 (2.33)
β2-microglobulin	67.9 (2.29)*	71.9 (2.15)*	75.7 (2.28)*	26.1 (2.15)
Creatinine	159.5 (3.60)	159.9 (3.50)	162.6 (3.54)	157.2 (3.50)
Phosphate	172.8 (4.84)*	179.8 (4.74)*	187.4 (4.78)*	152.8 (4.74)
Urea	216.9 (4.77)**	216.7 (4.65)**	217.2 (4.70)**	208.2 (4.65)
(B) Reduction ratio (%)
YKL-40	60.5 (1.66)*	66.4 (1.66)*	70.8 (1.66)*	19.2 (1.69)
α1-microglobulin	21.7 (2.42)*	22.6 (2.42)	29.3 (2.42)*	7.7 (2.48)
Complement factor D	56.9 (1.30)*	61.7 (1.30)*	64.4 (1.30)*	16.6 (1.33)
Myoglobin	63.1 (2.09)*	67.2 (2.09)*	68.9 (2.14)*	8.6 (2.14)
β2-microglobulin	71.5 (1.35)*	72.0 (1.35)*	72.1 (1.36)*	53.0 (1.36)
Creatinine	64.3 (1.31)**	62.9 (1.31)	63.1 (1.31)	62.5 (1.31)
Phosphate	58.8 (2.37)	56.9 (2.37)	57.6 (2.37)	56.8 (2.37)
Urea	71.3 (1.22)**	70.5 (1.22)	71.1 (1.22)	70.1 (1.22)

LS mean +/- standard error

Comparisons are based on a mixed model with fixed effects of period and study dialyzer type, and the random effect of subject.

*P < 0.001; **P < 0.05; (all versus HD).

The correct version of Table 5 is as follows:

Table 5

Open in new tab

(A) Overall clearances and (B) reduction ratios of medium-sized and small molecules in treatments in study 2

Cases	MCO AA HD	MCO BB HD	High-flux HD	HDF
(A) Overall clearance (mL/min)
α1-microglobulin	3.3 (0.20)*	4.6 (0.20)*	0.4 (0.20)	1.3 (0.20)
Complement factor D	26.3 (1.13)*	32.8 (1.10)*	8.2 (1.10)	12.4 (1.10)
Myoglobin	58.7 (2.46)*	62.7 (2.39)*	19.9 (2.39)	35.6 (2.46)
β2-microglobulin	84.7 (3.18)^,*	84.3 (3.10)^,*	55.1 (3.10)	73.1 (3.18)
Creatinine	210.4 (8.73)	203.7 (8.31)	208.9 (8.31)	210.0 (8.31)
Phosphate	209.8 (11.29)	218.0 (10.71)	193.2 (10.71)	194.5 (10.71)
Urea	281.9 (11.97)	268.1 (11.32)	277.0 (11.32)	263.4 (11.32)
(B) Reduction ratio (%)
YKL-40	63.6 (2.21)*	68.8 (2.21)*	29.8 (2.21)	44.8 (2.21)
α1-microglobulin	24.8 (8.97)***	30.1 (8.97)***	10.0 (8.97)	−8.9 (8.97)
Complement factor D	63.0 (1.73)*	66.7 (1.73)*	32.9 (1.73)	46.3 (1.73)
Myoglobin	67.9 (2.34)*	71.6 (2.34)*	37.2 (2.34)	59.3 (2.37)
β2-microglobulin	78.5 (1.32)^,**	78.9 (1.32)**	73.5 (1.32)	80.6 (1.33)
Creatinine	73.5 (1.45)	73.2 (1.45)	71.7 (1.45)	73.7 (1.45)
Phosphate	52.8 (2.13)	48.8 (2.13)	48.4 (2.13)	51.0 (2.13)
Urea	80.7 (1.33)*****	80.3 (1.33)****	79.4 (1.33)	81.6 (1.33)

Cases	MCO AA HD	MCO BB HD	High-flux HD	HDF
(A) Overall clearance (mL/min)
α1-microglobulin	3.3 (0.20)*	4.6 (0.20)*	0.4 (0.20)	1.3 (0.20)
Complement factor D	26.3 (1.13)*	32.8 (1.10)*	8.2 (1.10)	12.4 (1.10)
Myoglobin	58.7 (2.46)*	62.7 (2.39)*	19.9 (2.39)	35.6 (2.46)
β2-microglobulin	84.7 (3.18)^,*	84.3 (3.10)^,*	55.1 (3.10)	73.1 (3.18)
Creatinine	210.4 (8.73)	203.7 (8.31)	208.9 (8.31)	210.0 (8.31)
Phosphate	209.8 (11.29)	218.0 (10.71)	193.2 (10.71)	194.5 (10.71)
Urea	281.9 (11.97)	268.1 (11.32)	277.0 (11.32)	263.4 (11.32)
(B) Reduction ratio (%)
YKL-40	63.6 (2.21)*	68.8 (2.21)*	29.8 (2.21)	44.8 (2.21)
α1-microglobulin	24.8 (8.97)***	30.1 (8.97)***	10.0 (8.97)	−8.9 (8.97)
Complement factor D	63.0 (1.73)*	66.7 (1.73)*	32.9 (1.73)	46.3 (1.73)
Myoglobin	67.9 (2.34)*	71.6 (2.34)*	37.2 (2.34)	59.3 (2.37)
β2-microglobulin	78.5 (1.32)^,**	78.9 (1.32)**	73.5 (1.32)	80.6 (1.33)
Creatinine	73.5 (1.45)	73.2 (1.45)	71.7 (1.45)	73.7 (1.45)
Phosphate	52.8 (2.13)	48.8 (2.13)	48.4 (2.13)	51.0 (2.13)
Urea	80.7 (1.33)*****	80.3 (1.33)****	79.4 (1.33)	81.6 (1.33)

LS mean +/- standard error

Comparisons are based on a mixed model with fixed effects of period and study dialyzer type, and the random effect of subject.

*P < 0.001 versus HD and HDF; **P < 0.001 versus HD; ***P < 0.01 versus HDF; ****P < 0.05 versus HDF; *****P < 0.05 versus HD.

Table 5

Open in new tab

(A) Overall clearances and (B) reduction ratios of medium-sized and small molecules in treatments in study 2

Cases	MCO AA HD	MCO BB HD	High-flux HD	HDF
(A) Overall clearance (mL/min)
α1-microglobulin	3.3 (0.20)*	4.6 (0.20)*	0.4 (0.20)	1.3 (0.20)
Complement factor D	26.3 (1.13)*	32.8 (1.10)*	8.2 (1.10)	12.4 (1.10)
Myoglobin	58.7 (2.46)*	62.7 (2.39)*	19.9 (2.39)	35.6 (2.46)
β2-microglobulin	84.7 (3.18)^,*	84.3 (3.10)^,*	55.1 (3.10)	73.1 (3.18)
Creatinine	210.4 (8.73)	203.7 (8.31)	208.9 (8.31)	210.0 (8.31)
Phosphate	209.8 (11.29)	218.0 (10.71)	193.2 (10.71)	194.5 (10.71)
Urea	281.9 (11.97)	268.1 (11.32)	277.0 (11.32)	263.4 (11.32)
(B) Reduction ratio (%)
YKL-40	63.6 (2.21)*	68.8 (2.21)*	29.8 (2.21)	44.8 (2.21)
α1-microglobulin	24.8 (8.97)***	30.1 (8.97)***	10.0 (8.97)	−8.9 (8.97)
Complement factor D	63.0 (1.73)*	66.7 (1.73)*	32.9 (1.73)	46.3 (1.73)
Myoglobin	67.9 (2.34)*	71.6 (2.34)*	37.2 (2.34)	59.3 (2.37)
β2-microglobulin	78.5 (1.32)^,**	78.9 (1.32)**	73.5 (1.32)	80.6 (1.33)
Creatinine	73.5 (1.45)	73.2 (1.45)	71.7 (1.45)	73.7 (1.45)
Phosphate	52.8 (2.13)	48.8 (2.13)	48.4 (2.13)	51.0 (2.13)
Urea	80.7 (1.33)*****	80.3 (1.33)****	79.4 (1.33)	81.6 (1.33)

Cases	MCO AA HD	MCO BB HD	High-flux HD	HDF
(A) Overall clearance (mL/min)
α1-microglobulin	3.3 (0.20)*	4.6 (0.20)*	0.4 (0.20)	1.3 (0.20)
Complement factor D	26.3 (1.13)*	32.8 (1.10)*	8.2 (1.10)	12.4 (1.10)
Myoglobin	58.7 (2.46)*	62.7 (2.39)*	19.9 (2.39)	35.6 (2.46)
β2-microglobulin	84.7 (3.18)^,*	84.3 (3.10)^,*	55.1 (3.10)	73.1 (3.18)
Creatinine	210.4 (8.73)	203.7 (8.31)	208.9 (8.31)	210.0 (8.31)
Phosphate	209.8 (11.29)	218.0 (10.71)	193.2 (10.71)	194.5 (10.71)
Urea	281.9 (11.97)	268.1 (11.32)	277.0 (11.32)	263.4 (11.32)
(B) Reduction ratio (%)
YKL-40	63.6 (2.21)*	68.8 (2.21)*	29.8 (2.21)	44.8 (2.21)
α1-microglobulin	24.8 (8.97)***	30.1 (8.97)***	10.0 (8.97)	−8.9 (8.97)
Complement factor D	63.0 (1.73)*	66.7 (1.73)*	32.9 (1.73)	46.3 (1.73)
Myoglobin	67.9 (2.34)*	71.6 (2.34)*	37.2 (2.34)	59.3 (2.37)
β2-microglobulin	78.5 (1.32)^,**	78.9 (1.32)**	73.5 (1.32)	80.6 (1.33)
Creatinine	73.5 (1.45)	73.2 (1.45)	71.7 (1.45)	73.7 (1.45)
Phosphate	52.8 (2.13)	48.8 (2.13)	48.4 (2.13)	51.0 (2.13)
Urea	80.7 (1.33)*****	80.3 (1.33)****	79.4 (1.33)	81.6 (1.33)

LS mean +/- standard error

Comparisons are based on a mixed model with fixed effects of period and study dialyzer type, and the random effect of subject.

*P < 0.001 versus HD and HDF; **P < 0.001 versus HD; ***P < 0.01 versus HDF; ****P < 0.05 versus HDF; *****P < 0.05 versus HD.

doi: 10.1093/ndt/gfaa322

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]

Download all slides

Month:	Total Views:
May 2021	59
June 2021	104
July 2021	71
August 2021	80
September 2021	37
October 2021	39
November 2021	21
December 2021	12
January 2022	8
February 2022	9
March 2022	15
April 2022	11
May 2022	10
June 2022	10
July 2022	18
August 2022	14
September 2022	27
October 2022	27
November 2022	16
December 2022	14
January 2023	11
February 2023	3
April 2023	9
May 2023	7
June 2023	7
July 2023	2
August 2023	7
September 2023	4
October 2023	6
November 2023	10
December 2023	14
January 2024	13
February 2024	12
March 2024	8
April 2024	15
May 2024	17
June 2024	4
July 2024	17
August 2024	9
September 2024	8
October 2024	11
November 2024	9
December 2024	4
January 2025	1
February 2025	5
March 2025	13
April 2025	11
May 2025	1

Article Contents

Erratum to: Performance of Hemodialysis with Novel Medium Cut-Off Dialyzers

Comments

Citations

Views

Altmetric

Email alerts

Citing articles via

Latest

Most Read

Most Cited

Article Contents

Erratum to: Performance of Hemodialysis with Novel Medium Cut-Off Dialyzers

Comments

Citations

Views

Altmetric

Email alerts

Citing articles via

Latest

Most Read

Most Cited

This Feature Is Available To Subscribers Only